In recent years, branched-chain AA aminotransferase 1 (BCAT1) was discovered to be involved in the progression of glioma, ovarian cancer, liver cancer, breast cancer, and leukemia [50–54], but less in CSCs. Here, BCAT1 is linked to leukemia.